{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T09:07:13Z","timestamp":1648890433020},"reference-count":15,"publisher":"Japanese Society of Internal Medicine","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2017]]},"DOI":"10.2169\/internalmedicine.56.7562","type":"journal-article","created":{"date-parts":[[2017,1,14]],"date-time":"2017-01-14T17:10:54Z","timestamp":1484413854000},"page":"163-168","source":"Crossref","is-referenced-by-count":2,"title":["An Isolated Case of Late-onset Amyloidogenic Transthyretin Type Familial Amyloid Polyneuropathy Associated with a Mutant Transthyretin Substituting Methionine for Valine at Position 30 Showing Latent Progressive Cardiac Involvement Confirmed by Serial Annual Electrocardiograms"],"prefix":"10.2169","volume":"56","author":[{"given":"Chikako","family":"Sato","sequence":"first","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomofumi","family":"Takaya","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shumpei","family":"Mori","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kohei","family":"Hasegawa","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumitaka","family":"Soga","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidekazu","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiaki","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Department of Radiology, Kobe University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuya","family":"Nishii","sequence":"additional","affiliation":[{"name":"Department of Radiology, Kobe University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi K.","family":"Kono","sequence":"additional","affiliation":[{"name":"Department of Radiology, Kobe University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukiko","family":"Morinaga","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Pathology, Kobe University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hatsue","family":"Ishibashi-Ueda","sequence":"additional","affiliation":[{"name":"Department of Clinical Pathology, National Cerebral and Cardiovascular Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken-ichi","family":"Hirata","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Misu K, Hattori N, Nagamatsu M, et al. Late-onset familial amyloid polyneuropathy type I (transthyretin Met30-associated familial amyloid polyneuropathy) unrelated to endemic focus in Japan. Brain 122: 1951-1962, 1999.","DOI":"10.1093\/brain\/122.10.1951"},{"key":"2","doi-asserted-by":"publisher","unstructured":"2. Rapezzi C, Merlini G, Quarta CC, et al. Systemic cardiac amyloidoses: disease profiles and clinical courses of the 3 main types. Circulation 120: 1203-1212, 2009.","DOI":"10.1161\/CIRCULATIONAHA.108.843334"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Takigawa M, Hashimura K, Ishibashi-Ueda H, et al. Annual electrocardiograms consistent with silent progression of cardiac involvement in sporadic familial amyloid polyneuropathy: a case report. Intern Med 49: 139-144, 2010.","DOI":"10.2169\/internalmedicine.49.2703"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Ikeda S. Cardiac amyloidosis: heterogenous pathogenic backgrounds. Intern Med 43: 1107-1114, 2004.","DOI":"10.2169\/internalmedicine.43.1107"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Takei Y, Hattori T, Tokuda T, et al. Senile systemic amyloidosis starting as bilateral carpal and left ulnar tunnel syndrome. Intern Med 42: 1050-1051, 2003.","DOI":"10.2169\/internalmedicine.42.1050"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Dungu JN, Anderson LJ, Whelan CJ, Hawkins PN. Cardiac transthyretin amyloidosis. Heart 98: 1546-1554, 2012.","DOI":"10.1136\/heartjnl-2012-301924"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Buxbaum J, Anan I, Suhr O. Serum transthyretin levels in Swedish TTR V30M carriers. Amyloid 17: 83-85, 2010.","DOI":"10.3109\/13506129.2010.483118"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. van Gameren II, Hazenberg BP, Bijzet J, van Rijswijk MH. Diagnostic accuracy of subcutaneous abdominal fat tissue aspiration for detecting systemic amyloidosis and its utility in clinical practice. Arthritis Rheum 54: 2015-2021, 2006.","DOI":"10.1002\/art.21902"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Bokhari S, Casta\u00f1o A, Pozniakoff T, Deslisle S, Latif F, Maurer MS. <sup>99m<\/sup>Tc-pyrophosphate scintigraphy for differentiating light-chain cardiac amyloidosis from transthyretin-related familial and senile cardiac amyloidoses. Circ Cardiovasc Imaging 6: 195-201, 2013.","DOI":"10.1161\/CIRCIMAGING.112.000132"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Minamisawa M, Koyama J, Sekijima Y, et al. Comparison of the standard and speckle tracking echocardiographic features of wild-type and mutated transthyretin cardiac amyloidoses. Eur Heart J Cardiovasc Imaging 17: 402-410, 2016.","DOI":"10.1093\/ehjci\/jew003"},{"key":"11","doi-asserted-by":"publisher","unstructured":"11. Olofsson BO, Backman C, Karp K, Suhr OB. Progression of cardiomyopathy after liver transplantation in patients with familial amyloidotic polyneuropathy, Portuguese type. Transplantation 73: 745-751, 2002.","DOI":"10.1097\/00007890-200203150-00015"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Ihse E, Suhr OB, Hellman U, Westermark P. Variation in amount of wild-type transthyretin in different fibril and tissue types in ATTR amyloidosis. J Mol Med 89: 171-180, 2011.","DOI":"10.1007\/s00109-010-0695-1"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Ueda M, Ando Y. Recent advances in transthyretin amyloidosis therapy. Transl Neurodegener 3: 19, 2014.","DOI":"10.1186\/2047-9158-3-19"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Coelho T, Maia LF, da Silva AM, et al. Long-term effects of tafamidis for the treatment of transthyretin familial amyloid polyneuropathy. J Neurol 260: 2802-2814, 2013.","DOI":"10.1007\/s00415-013-7051-7"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Maurer MS, Grogan DR, Judge DP, et al. Tafamidis in transthyretin amyloid cardiomyopathy: effects on transthyretin stabilization and clinical outcomes. Circ Heart Fail 8: 519-526, 2015.","DOI":"10.1161\/CIRCHEARTFAILURE.113.000890"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/56\/2\/56_56.7562\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T04:16:46Z","timestamp":1498364206000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/56\/2\/56_56.7562\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":15,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.56.7562","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}